ChemicalBook >> CAS DataBase List >>KI16425

KI16425

CAS No.
355025-24-0
Chemical Name:
KI16425
Synonyms
CS-88;KI-6425;Debio 0719;Ki16425, >=98%;KI16425 USP/EP/BP;KI-16425; KI 16425;Ki16425 (Debio 0719);KI16425;KI-16425; KI 16425;Ki 16425, competitive, potent and reversible antagonist to LPA;Ki 16425, 98%, competitive, potent and reversible antagonist to LPA
CBNumber:
CB9497429
Molecular Formula:
C23H23ClN2O5S
Molecular Weight:
474.96
MDL Number:
MFCD06798341
MOL File:
355025-24-0.mol
MSDS File:
SDS
Last updated:2023-06-30 15:45:59

KI16425 Properties

Melting point 59.5-60.5 °C
Boiling point 623.7±55.0 °C(Predicted)
Density 1.353
storage temp. -20°C
solubility DMSO: 16 mg/mL
form solid
pka 4.32±0.10(Predicted)
color white
FDA UNII 83W49JT69B

SAFETY

Risk and Safety Statements

Hazard Codes  Xi
Risk Statements  36/37/38
Safety Statements  26-36
WGK Germany  3
HS Code  29349990

KI16425 price More Price(34)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML0971 Ki 16425 ≥98% (HPLC) 355025-24-0 5mg $118 2024-03-01 Buy
Sigma-Aldrich SML0971 Ki 16425 ≥98% (HPLC) 355025-24-0 25mg $478 2024-03-01 Buy
Cayman Chemical 10012659 Ki 16425 ≥95% 355025-24-0 1mg $37 2024-03-01 Buy
Cayman Chemical 10012659 Ki 16425 ≥95% 355025-24-0 5mg $98 2024-03-01 Buy
Cayman Chemical 10012659 Ki 16425 ≥95% 355025-24-0 10mg $142 2024-03-01 Buy
Product number Packaging Price Buy
SML0971 5mg $118 Buy
SML0971 25mg $478 Buy
10012659 1mg $37 Buy
10012659 5mg $98 Buy
10012659 10mg $142 Buy

KI16425 Chemical Properties,Uses,Production

Description

Lysophosphatidic acid (LPA) is a bioactive lipid mediator that signals through five distinct G protein-coupled receptors (LPA1-5). Ki16425 is a LPA receptor antagonist with selectivity for LPA1 and LPA3. It exhibits Ki values of 0.34, 6.5, and 0.93 μM for the human LPA1, LPA2, and LPA3 receptors, respectively, as determined by measuring inositol phosphate production in RH7777-transfected cells. Ki1642, at 10 μM, significantly blocks the response of a variety of cancer cell lines to LPA-induced cell migration.

Uses

Ki16425 is a competitive, potent and reversible antagonist to LPA1, LPA2 and LPA3.

Uses

Ki 16425 has been used as a chemical inhibitor to study the regulation of LPA (lysophosphatidic acid) on LPAR(LPA receptor) subtypes.

Definition

ChEBI: 3-[({4-[4-({[1-(2-chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]phenyl}methyl)sulfanyl]propanoic acid is a member of the class of isoxazoles that is the carbamate ester obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)ethyl hydrogen carbonate with the amino group of 3-({[4-(4-amino-3-methyl-1,2-oxazol-5-yl)phenyl]methyl}sulfanyl)propanoic acid. It is a member of isoxazoles, a carbamate ester, a member of monochlorobenzenes, an organic sulfide and a monocarboxylic acid.

Biochem/physiol Actions

Ki 16425 possesses a short-lived inhibitory activity. It has been studied that Ki 16425 is effective in the inhibition of neuropathic pain‐like behaviors.

storage

Store at +4°C

References

[1]. ohta h, sato k, murata n, damirin a, malchinkhuu e, kon j, kimura t, tobo m, yamazaki y, watanabe t, yagi m, sato m, suzuki r, murooka h, sakai t, nishitoba t, im ds, nochi h, tamoto k, tomura h, okajima f. ki16425, a subtype-selective antagonist for edg-family lysophosphatidic acid receptors. mol pharmacol. 2003 oct;64(4):994-1005.
[2]. ruisanchez é, dancs p, kerék m, németh t, faragó b, balogh a, patil r, jennings bl, liliom k, malik ku, smrcka av, tigyi g, benyó z. lysophosphatidic acid induces vasodilation mediated by lpa1 receptors, phospholipase c, and endothelial nitric oxide synthase. faseb j. 2014 feb;28(2):880-90.
[3]. su sc, hu x, kenney pa, merrill mm, babaian kn, zhang xy, maity t, yang sf, lin x, wood cg. autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma. clin cancer res. 2013 dec 1;19(23):6461-72.
[4]. david m, sahay d, mege f, descotes f, leblanc r, ribeiro j, clézardin p, peyruchaud o. identification of heparin-binding egf-like growth factor (hb-egf) as a biomarker for lysophosphatidic acid receptor type 1 (lpa1) activation in human breast and prostate cancers. plos one. 2014 may 14;9(5):e97771.

KI16425 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 106)Suppliers
Supplier Tel Email Country ProdList Advantage
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806 sales@capotchem.com China 29797 60
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 967 58
Hubei Jusheng Technology Co.,Ltd.
18871490254 linda@hubeijusheng.com CHINA 28180 58
Alchem Pharmtech,Inc.
8485655694 sales@alchempharmtech.com United States 63711 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 47465 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29627 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10523 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6393 58
LEAP CHEM CO., LTD.
+86-852-30606658 market18@leapchem.com China 24738 58

KI16425 Spectrum

3-[[[4-[4-[[[1-(2-chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazoly]phenyl]methyl]thio]-propanoic acid 3-[[[4-[4-[[[1-(2-Chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]phenyl]methyl]thio]propanoic acid KI-6425 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl)-3-methylisoxazol-5-yl)benzylthio)propanoic acid Ki16425, >=98% KI16425;KI-16425; KI 16425 3-[[4-[4-[1-(2-chlorophenyl)ethoxycarbonylamino]-3-methyl-isoxazol-5-yl]phenyl]methylsulfanyl]propanoic acid 3-((4-(4-(((1-(2-Chlorophenyl)ethoxy)carbonyl)amino)-3-methylisoxazol-5-yl)benzyl)thio)propano CS-88 KI-16425; KI 16425 Ki 16425, 98%, competitive, potent and reversible antagonist to LPA Debio 0719 Propanoic acid, 3-[[[4-[4-[[[1-(2-chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]phenyl]methyl]thio]- KI16425 USP/EP/BP Ki16425 (Debio 0719) Ki 16425, competitive, potent and reversible antagonist to LPA 355025-24-0 Inhibitors